Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Nat Commun
.
2024 Apr 16;15(1):3273.
doi: 10.1038/s41467-024-47675-w.
Authors
Tikvah K Hayes
1
2
3
,
Elisa Aquilanti
1
2
,
Nicole S Persky
2
4
5
,
Xiaoping Yang
4
,
Erica E Kim
1
,
Lisa Brenan
2
,
Amy B Goodale
4
,
Douglas Alan
4
,
Ted Sharpe
6
,
Robert E Shue
1
2
,
Lindsay Westlake
2
,
Lior Golomb
1
2
,
Brianna R Silverman
1
,
Myshal D Morris
7
,
Ty Running Fisher
7
,
Eden Beyene
7
,
Yvonne Y Li
1
2
,
Andrew D Cherniack
1
2
,
Federica Piccioni
4
8
,
J Kevin Hicks
9
,
Andrew S Chi
10
,
Daniel P Cahill
10
,
Jorg Dietrich
11
,
Tracy T Batchelor
12
,
David E Root
4
,
Cory M Johannessen
2
13
,
Matthew Meyerson
14
15
Affiliations
1
Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
2
Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
3
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
4
Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
5
Aera Therapeutics, Cambridge, MA, USA.
6
Data Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.
7
Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
8
Merck Research Laboratories, Cambridge, MA, USA.
9
Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
10
Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
11
Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
12
Department of Neurology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
13
Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
14
Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.
15
Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA. matthew_meyerson@dfci.harvard.edu.
PMID:
38627431
PMCID:
PMC11021560
DOI:
10.1038/s41467-024-47675-w
No abstract available
Publication types
Published Erratum